Gene Mutation Profile and Risk Stratification in AML1-ETO-Positive Acute Myeloid Leukemia Based on Next-Generation Sequencing

被引：0
|
作者：
Yu, Guopan [1 ]
Yin, Changxin [1 ]
Wu, Fuqun [2 ]
Jiang, Ling [1 ]
Zheng, Zhongxin [1 ]
Xu, Dan [1 ]
Zhou, Jiaheng [3 ]
Jiang, Xuejie [4 ]
Liu, Qifa [5 ]
Meng, Fanyi [1 ,2 ]
机构：
[1] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China
[2] Kanghua Hosp, Hematopathy Diag & Therapy Ctr, Dongguan, Peoples R China
[3] Southern Med Univ, Guangzhou, Guangdong, Peoples R China
[4] Southern Med Univ, Dept Hematol, Nanfang Hosp, Houston, TX USA
[5] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-113494
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5249
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Gene mutation profile and risk stratification in AML1-ETO-positive acute myeloid leukemia based on next-generation sequencing
    Yu, Guopan
    Yin, Changxin
    Wu, Fuqun
    Jiang, Ling
    Zheng, Zhongxin
    Xu, Dan
    Zhou, Jiaheng
    Jiang, Xuejie
    Liu, Qifa
    Meng, Fanyi
    ONCOLOGY REPORTS, 2019, 42 (06) : 2333 - 2344
  • [2] A New Multi-Factor Risk Score System Depending on Gene Mutation and Overexpression for Predicting the Outcome in AML1-ETO-Positive Acute Myeloid Leukemia
    Yu, Guo-Pan
    Yin, Changxin
    Wu, Fuqun
    Xu, Dan
    Zheng, Zhongxin
    Jiang, Ling
    Chen, Fang
    Jiang, Xuejie
    Liu, Qifa
    Meng, Fanyi
    BLOOD, 2017, 130
  • [3] MUTATIONAL PROFILE BY NEXT-GENERATION SEQUENCING IN ACUTE MYELOID LEUKEMIA (AML): A SINGLE CENTER EXPERIENCE
    Piras, G.
    Asproni, R.
    Monne, M.
    Palmas, A. D.
    Uras, A.
    Marziliano, N.
    Latte, G.
    HAEMATOLOGICA, 2016, 101 : 670 - 670
  • [4] Gene Mutation and MRD-Directed Risk Stratification Treatment Improves Long Term Survival of the Patients with AML1-ETO-Positive AML
    Xu, Dan
    Yang, Ying
    Yin, Zhao
    Tu, Sanfang
    Nie, Danian
    Sun, Qixin
    Huang, Zhengqian
    Zhang, Yu
    Yu, Guopan
    BLOOD, 2022, 140 : 9097 - 9097
  • [5] Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing
    Wang, Bianhong
    Liu, Yangyang
    Hou, Guangyuan
    Wang, Lili
    Lv, Na
    Xu, Yuanyuan
    Xu, Yihan
    Wang, Xiuli
    Xuan, Zhaoling
    Jing, Yu
    Li, Honghua
    Jin, Xiangshu
    Deng, Ailing
    Wang, Li
    Gao, Xiaoning
    Dou, Liping
    Liang, Junbin
    Chen, Chongjian
    Li, Yonghui
    Yu, Li
    ONCOTARGET, 2016, 7 (22) : 32065 - 32078
  • [6] RISK STRATIFICATION OF ACUTE MYELOID LEUKEMIA BASED ON CALCULATED KARYOTYPING BY NEXT GENERATION SEQUENCING
    Kremer, J.
    Koch, V.
    Thoelken, C.
    Chung, H. R.
    Thiede, C.
    Meggendorfer, M.
    Haferlach, T.
    Brendel, C.
    Neubauer, A.
    Mack, E. K. M.
    ANNALS OF HEMATOLOGY, 2023, 102 (SUPPL 1) : S58 - S59
  • [7] Risk stratification of acute myeloid leukemia based on calculated karyotyping by next generation sequencing
    Kremer, J.
    Koch, V
    Thoelken, C.
    Chung, H. -R
    Thiede, C.
    Neubauer, A.
    Mack, E. K. M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 114 - 114
  • [8] Effects of the DNA methylase inhibitor zebularine on global gene expression in AML1-ETO-positive acute myeloid leukemia.
    Flotho, C
    Song, GC
    Downing, JR
    BLOOD, 2005, 106 (11) : 840A - 840A
  • [9] Amyloid precursor protein has clinical and prognostic significance in AML1-ETO-positive acute myeloid leukemia
    Yu, Guopan
    Yin, Changxin
    Jiang, Ling
    Xu, Dan
    Zheng, Zhongxin
    Wang, Zhixiang
    Wang, Chunli
    Zhou, Hongsheng
    Jiang, Xuejie
    Liu, Qifa
    Meng, Fanyi
    ONCOLOGY LETTERS, 2018, 15 (01) : 917 - 925
  • [10] Impact of next-generation sequencing (NGS) on treatment selection in acute myeloid leukemia (AML).
    Assi, Rita Elias
    Pierola, Ana Alfonso
    Devendra, K. C.
    Abaza, Yasmin Mohammed
    Abou Zahr, Abdallah
    Chamoun, Kamal
    Montalban-Bravo, Guillermo
    Takahashi, Koichi
    Jabbour, Elias
    Kadia, Tapan M.
    Ravandi, Farhad
    Cortes, Jorge E.
    Dinardo, Courtney Denton
    Daver, Naval Guastad
    Borthakur, Gautam
    Pemmaraju, Naveen
    Konopleva, Marina
    Futreal, Andrew
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345